These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32900459)

  • 61. Response by Ducroux et al to Letter Regarding Article, "Thrombus Neutrophil Extracellular Traps Content Impair tPA-Induced Thrombolysis in Acute Ischemic Stroke".
    Ducroux C; Desilles JP; Ho-Tin-Noe B
    Stroke; 2018 Jul; 49(7):e266. PubMed ID: 29866748
    [No Abstract]   [Full Text] [Related]  

  • 62. tPA for stroke.
    Clin Privil White Pap; 2012 Apr; (65):1-17. PubMed ID: 22715522
    [No Abstract]   [Full Text] [Related]  

  • 63. Contemporary acute ischemic stroke therapy with intravenous recombinant tissue plasminogen activator.
    Frank JI
    Clin Neurosurg; 2000; 46():261-6. PubMed ID: 10944682
    [No Abstract]   [Full Text] [Related]  

  • 64. Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke.
    Xian Y; Smith EE; Zhao X; Peterson ED; Olson DM; Hernandez AF; Bhatt DL; Saver JL; Schwamm LH; Fonarow GC
    Stroke; 2014 May; 45(5):1387-95. PubMed ID: 24713527
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Letter by Chao et al regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses".
    Chao AC; Po HL; Chan L
    Stroke; 2014 Dec; 45(12):e303. PubMed ID: 25342029
    [No Abstract]   [Full Text] [Related]  

  • 66. Statement outlines prevention measures for ischemic stroke.
    Rollins G
    Rep Med Guidel Outcomes Res; 2001 Feb; 12(3):7-9. PubMed ID: 11767793
    [No Abstract]   [Full Text] [Related]  

  • 67. Letter by van de Graaf et al Regarding Article, "Thrombus Neutrophil Extracellular Traps Content Impair tPA-Induced Thrombolysis in Acute Ischemic Stroke".
    van de Graaf RA; van Beusekom HMM; Roozenbeek B
    Stroke; 2018 Jul; 49(7):e265. PubMed ID: 29866759
    [No Abstract]   [Full Text] [Related]  

  • 68. Hyperacute stroke therapy with tissue plasminogen activator.
    Alberts MJ
    Am J Cardiol; 1997 Aug; 80(4C):29D-34D; discussion 35D-39D. PubMed ID: 9284041
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A literature review of cost-effectiveness of intravenous recombinant tissue plasminogen activator for treating acute ischemic stroke.
    Joo H; Wang G; George MG
    Stroke Vasc Neurol; 2017; 2(2):73-83. PubMed ID: 28736623
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intraarterial recombinant tissue plasminogen activator for ischemic stroke: an accelerated dosing regimen.
    Coplin WM; Broderick J; Tomsick TT
    Neurosurgery; 2001 Jul; 49(1):228-9. PubMed ID: 11440452
    [No Abstract]   [Full Text] [Related]  

  • 71. Guidelines for extending the tissue plasminogen activator treatment window for ischemic stroke.
    Asimos AW
    Stroke; 2009 Nov; 40(11):e633. PubMed ID: 19797700
    [No Abstract]   [Full Text] [Related]  

  • 72. Drip-and-Ship Thrombolytic Therapy for Acute Ischemic Stroke.
    Deguchi I; Mizuno S; Kohyama S; Tanahashi N; Takao M
    J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):61-67. PubMed ID: 28867523
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Administration of tissue plasminogen activator for acute ischemic stroke in a rural Wisconsin hospital.
    Charipar R; Charipar E
    WMJ; 2008 Jul; 107(4):176-80. PubMed ID: 18702433
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Emergency treatment of ischemic stroke.
    Connors JJ
    J Invasive Cardiol; 1999 Feb; 11(2):93-5; discussion 95-6. PubMed ID: 10745490
    [No Abstract]   [Full Text] [Related]  

  • 75. Medicine. Stroke--tPA and the clinic.
    Marler JR; Goldstein LB
    Science; 2003 Sep; 301(5640):1677. PubMed ID: 14500967
    [TBL] [Abstract][Full Text] [Related]  

  • 76. EMD & acute stroke response.
    Sinclair R; Marler JR
    JEMS; 2000 Oct; 25(10):28-9. PubMed ID: 11141763
    [No Abstract]   [Full Text] [Related]  

  • 77. 20 questions about emergency stroke & cardiac care. Interview by Chad Brocato.
    Gordon DL; Rosenberg D
    JEMS; 2000 Oct; 25(10):22-7, 30. PubMed ID: 11141762
    [No Abstract]   [Full Text] [Related]  

  • 78. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
    Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
    Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Emergency identification and treatment of acute ischemic stroke.
    Kasner SE; Grotta JC
    Ann Emerg Med; 1997 Nov; 30(5):642-53. PubMed ID: 9360577
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ischemic stroke and excellent recovery after administration of intravenous tissue plasminogen activator.
    Jain SV; Morton LD
    Pediatr Neurol; 2008 Feb; 38(2):126-9. PubMed ID: 18206794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.